OOIR: Observatory of International Research

Papers

(The H4-Index of Cancer is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation	424
Dietary supplement use among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort Study	255
What are the most effective exercise, physical activity and dietary interventions to improve body composition in women diagnosed with or at high‐risk of breast cancer? A systematic review and network	211
Outcomes of patients with newly diagnosed acute myeloid leukemia with FLT3‐tyrosine kinase domain mutations: Prognostic implications of NPM1 co‐mutation	176
A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first‐line treatment for patients with melanoma in‐transit metastases	171
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK‐positive advanced non–small cell lung cancer	124
Effect of smoking reduction, cessation, and resumption on cancer risk: A nationwide cohort study	119
International perspectives on the development, application, and evaluation of a multicancer early detection strategy	95
Unveiling the impact of chemotherapy in patients with breast cancer: A longitudinal study on peripheral inflammation, multimodal magnetic resonance imaging, and cognition	90
Radiation necrosis in renal cell carcinoma brain metastases treated with checkpoint inhibitors and radiosurgery: An international multicenter study	70
Association of high‐dose radiotherapy with improved survival in patients with newly diagnosed low‐grade gliomas	67
Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials	62
Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data	58
Financial toxicity impact on younger versus older adults with cancer in the setting of care delivery	57
Cutaneous β‐HPV may predict cutaneous squamous cell carcinoma	56
Impact of TAILORx on chemotherapy prescribing and 21‐gene recurrence score–guided treatment costs in a population‐based cohort of patients with breast cancer	56
The role of relative advantage for development of sequencing‐based diagnostics for pediatric cancer in low‐ and middle‐income countries	55
Impact of African ancestry on the relationship between body mass index and survival in an early‐stage breast cancer trial (ECOG‐ACRIN E5103)	55
	54
What’s the reality for CDK4/6 inhibitors: Clinical trials or real‐world evidence?	54
Active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer	53
Issue Information	53
Effect of an mHealth intervention on physical activity outcomes among young adult cancer survivors: The IMPACT randomized controlled trial	52
The economics of advanced and unresectable hepatocellular carcinoma	51
New standard of care for multiple myeloma?	51

Improved survival and decreased cancer deaths in young adults with cancer after passage of the Affordable Care Act Dependent Coverage Expansion	49
Best of both worlds? Linking comprehensive and noncomprehensive cancer centers	49
Occurrence of breast‐cancer–related lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: A two‐arm randomized clinical trial	49
Redefining the “crown”: Approaching chemotherapy‐induced alopecia among Black patients with breast cancer	49
Updated American Cancer Society lung cancer screening guidelines	49
Targeting HER2 in lung cancers: Evolving treatment landscape and drug development strategies	49
MRI is more accurate than a PSMA PET/CT scan for prostate cancer diagnosis	48
Smoking cessation services and shared decision‐making practices among lung cancer screening facilities: A cross‐sectional study	47
Serum of interleukin‐6 and procalcitonin as early diagnostic markers for the identification of poor hematopoietic reconstitution following allogeneic hematopoietic stem cell transplantation	47
Potential of circulating tumor DNA to refine immunotherapy	47
Erratum to “Landscape of DNA damage response gene alterations in breast cancer: A comprehensive investigation”	45
Multicenter study of pediatric Epstein‐Barr virus–negative monomorphic post solid organ transplant lymphoproliferative disorders	44
Reply to “Enhancing the role of social work in managing cancer risks among LGBTQ+ populations” and “The urgency of systematically acquiring sexual orientation and gender identity data to ensure equity	44
Patterns of failure in pediatric medulloblastoma and implications for hippocampal sparing	44
Ovarian juvenile granulosa cell tumor: A report from the International Ovarian and Testicular Stromal Tumor and International Pleuropulmonary Blastoma/DICER1 Registries	44
Aspirin but not statins is inversely related to gastric cancer with a duration–risk effect: Results from the Stomach Cancer Pooling Project Consortium	43
Family characteristics and childcare patterns associated with early social functioning in cancer‐bereaved parents	43
	42